Evidence mapPaperPMID 41859121Full record

ArticleFrontiers in immunology2026

Divergent macrophage responses to Influenza A virus and

Javier Arranz-Herrero, Jana Baranda, Sergio Rius-Rocabert, Mikel Moreno-Vadillo, Ivan Gonzalez-Ruiz, Alberto Miranda-Bedate, Elena Pinelli, Ines Inchausti-Moya, Sara Izpura-Luis, Vicent Tur-Planells and 8 more

Abstract read
In one paragraph

Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Javier Arranz-HerreroTransplant Immunology Unit, National Center of Microbiology, Instituto de Salud Carlos III, Madrid, Spain.
Jana BarandaTransplant Immunology Unit, National Center of Microbiology, Instituto de Salud Carlos III, Madrid, Spain.
Sergio Rius-RocabertMicrobiology Section, Dpto. Ciencias (CC), Farmacéuticas y de la Salud, Facultad de Farmacia, Universidad San Pablo-CEU, Madrid, Spain.
Mikel Moreno-VadilloMicrobiology Section, Dpto. Ciencias (CC), Farmacéuticas y de la Salud, Facultad de Farmacia, Universidad San Pablo-CEU, Madrid, Spain.
Ivan Gonzalez-RuizMicrobiology Section, Dpto. Ciencias (CC), Farmacéuticas y de la Salud, Facultad de Farmacia, Universidad San Pablo-CEU, Madrid, Spain.
Alberto Miranda-BedateCenter for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, Netherlands.
Elena PinelliCenter for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, Netherlands.
Ines Inchausti-MoyaMicrobiology Section, Dpto. Ciencias (CC), Farmacéuticas y de la Salud, Facultad de Farmacia, Universidad San Pablo-CEU, Madrid, Spain.
Sara Izpura-LuisMicrobiology Section, Dpto. Ciencias (CC), Farmacéuticas y de la Salud, Facultad de Farmacia, Universidad San Pablo-CEU, Madrid, Spain.
Vicent Tur-PlanellsMicrobiology Section, Dpto. Ciencias (CC), Farmacéuticas y de la Salud, Facultad de Farmacia, Universidad San Pablo-CEU, Madrid, Spain.
Paloma RecheMicrobiology Section, Dpto. Ciencias (CC), Farmacéuticas y de la Salud, Facultad de Farmacia, Universidad San Pablo-CEU, Madrid, Spain.
Paloma FernandezInstituto de Medicina Molecular Aplicada-Nemesio Díez (IMMA-ND), Facultad de Medicina, Universidad San Pablo-CEU, CEU Universities, Madrid, Spain.
Yolanda RevillaCentro de Biología Molecular Severo Ochoa (CSIC-UAM), Universidad Autónoma de Madrid, Cantoblanco, Madrid, Spain.
Gustavo Del RealDepartment of Biotechnology, National Institute of Agricultural and Food Research and Technology (INIA-CSIC), Madrid, Spain.
Adolfo García-SastreDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
César B Gutiérrez-MartínDepartment of Animal Health, Faculty of Veterinary, Universidad de León, León, Spain.
Jordi OchandoTransplant Immunology Unit, National Center of Microbiology, Instituto de Salud Carlos III, Madrid, Spain.
Estanislao Nistal-VillanMicrobiology Section, Dpto. Ciencias (CC), Farmacéuticas y de la Salud, Facultad de Farmacia, Universidad San Pablo-CEU, Madrid, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Respiratory coinfections involving Influenza viruses, including Influenza A viruses (IAV) and bacteria, significantly worsen disease severity and remain a major public health concern, particularly during seasonal and pandemic flu outbreaks. Among bacterial pathogens, Methods: We developed an Results: RNA-Seq and OLINK proteomic analyses revealed that simultaneous coinfection elicits a synergistic inflammatory response similar to that caused by Spn alone, with strong activation of NF-κB-dependent genes. In sequential superinfection, responses were shaped by viral priming, with bacterial challenge further amplifying genes linked to inflammation and fibrin clot formation, potentially contributing to disease severity. These effects were consistent across different IAV subtypes when tested in combination with porcine

Indexed as

CoinfectionInfluenza A virusMacrophagesOrthomyxoviridae InfectionsPneumococcal InfectionsStreptococcus pneumoniaeSuperinfectionAnimalsHumansMiceSwinecoinfectioninfluenzain vitroStreptococcussuperinfectiontranscriptomics

Identifiers

PMID41859121
PMCPMC12996220

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.